Barrett's esophagus: proton pump inhibitors and chemoprevention II

Richter, J.E.; Penagini, R.; Tenca, A.; Pohl, D.; Dvorak, K.; Goldman, A.; Savarino, E.; Zentilin, P.; Savarino, V.; Watson, J.T.; Wong, R.K.; Pace, F.; Casini, V.; Peura, D.A.; Herzig, S.J.; Kamiya, T.; Pelosini, I.; Scarpignato, C.; Armstrong, D.; Devault, K.R.; Bechi, P.; Taddei, A.; Freschi, G.; Ringressi, M.N.; Degli'Innocenti, D.R.; Castiglione, F.; Masini, E.; Hunt, R.H.

doi:10.1111/j.1749-6632.2011.06048.x

The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48-h pH monitoring, pH-impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual-release delivery PPIs, immediate-release PPIs, long-term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti-inflammatory drugs (NSAIDs), and new PPIs.

Barrett's esophagus: proton pump inhibitors and chemoprevention II / J.E. Richter, R. Penagini, A. Tenca, D. Pohl, K. Dvorak, A. Goldman, E. Savarino, P. Zentilin, V. Savarino, J.T. Watson, R.K. Wong, F. Pace, V. Casini, D.A. Peura, S.J. Herzig, T. Kamiya, I. Pelosini, C. Scarpignato, D. Armstrong, K.R. DeVault, P. Bechi, A. Taddei, G. Freschi, M.N. Ringressi, D.R. Degli'Innocenti, F. Castiglione, E. Masini, R.H. Hunt. - In: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. - ISSN 0077-8923. - 1232:1(2011 Sep), pp. 114-139. [10.1111/j.1749-6632.2011.06048.x]

Barrett's esophagus: proton pump inhibitors and chemoprevention II

J. E. Richter;R. Penagini^Secondo;A. Tenca;D. Pohl;K. Dvorak;A. Goldman;E. Savarino;P. Zentilin;V. Savarino;J. T. Watson;R. K. Wong;F. Pace;V. Casini;D. A. Peura;S. J. Herzig;T. Kamiya;I. Pelosini;C. Scarpignato;D. Armstrong;K. R. DeVault;P. Bechi;A. Taddei;G. Freschi;M. N. Ringressi;D. R. Degli'Innocenti;F. Castiglione;E. Masini;R. H. Hunt

2011

Abstract

The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48-h pH monitoring, pH-impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual-release delivery PPIs, immediate-release PPIs, long-term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti-inflammatory drugs (NSAIDs), and new PPIs.

Scheda breve

Scheda completa

Scheda completa (DC)

	Parole chiave
	
			pH testing; 48-h acid reflux monitoring; ACG guidelines; PPI therapy; Symptom Association Probability; GERD; bile acids; Bilitec probe; functional dyspepsia; functional heartburn; Barrett's esophagus; acid suppression; NERD; ilaprazole; tenatoprazole; CMA omeprazole; rabeprazole; dexlansoprazole; fundic glands polyp; Clostridium difficile; erosive esophigitis; pharmacokinetic changes; GABA(B); baclofen; TLESR; nocturnal acid breakthrough; COX-2 inhibitors; AspECT trial; STU-Na; API-023
		
	Settori scientifico-disciplinari dell'articolo
	
			Settore MED/12 - Gastroenterologia
		
	Data di pubblicazione
	
			set-2011
		
	Rivista in ANCE
	
			ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
		
	DOI
	
			https://dx.doi.org/10.1111/j.1749-6632.2011.06048.x
		
	Tipologia
	
			Article (author)
		
	Appare nelle tipologie:
	
			01 - Articolo su periodico

File in questo prodotto:

File	Dimensione	Formato
Ann N Y Acad Sci 2011.pdf accesso riservato Tipologia: Publisher's version/PDF Dimensione 702.17 kB Formato Adobe PDF Visualizza/Apri Richiedi una copia	702.17 kB	Adobe PDF	Visualizza/Apri Richiedi una copia

Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/179570

Citazioni

3

10

9

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca